Cannabis stocks have been the biggest winners and also the biggest losers over the last five years.
But if you’re a long-term Motley Fool investor, it’s not too late to get into cannabis stocks.
In Europe it’s a similar scenario, with many European countries legalizing it for medical use, though we’re still waiting on legalization for recreational purposes.
It comes down to partnerships, advertising, cost savings, mergers, and of course where these companies put their focus around the world.
But how long can you do that and hope for legalization? That’s the question many cannabis stocks and their investors have right now.
Tilray, for its part, has been going through a spending spree, acquiring companies at an ultra-low cost.
Tilray purchased US$211 million in debt from Hexo, creating a “strategic alliance” between the two that would see up to $50 million of production efficiencies in the next two years.
This was seen with it touching practically every sector of the cannabis industry.
But it also has partnerships in place to acquire cannabis companies for when U.S.
A decade from now, this will be an industry of massive proportions, and these two companies are likely to be at the forefront.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor.